Patient preferences for treatment of major depressive disorder and the impact on health outcomes: A systematic review

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 13, Issue 5, 2011, Pages

  Gelhorn, Heather L ^a   Sexton, Chris C ^a   Classi, Peter M ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; IMIPRAMINE; MIRTAZAPINE; PLACEBO;

CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; MAJOR DEPRESSION; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PATIENT PREFERENCE; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 84856065606     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.11r01161     Document Type: Review

References (58)

1. Churchill R, Khaira M, Gretton V, et al; Nottingham Counselling and Antidepressants in Primary Care (CAPC) Study Group. Treating depression in general practice: factors affecting patients' treatment preferences. Br J Gen Pract. 2000;50(460):905-906.
2. US Dept of Health and Human Welfare. Depression in Primary Care. Vol 2. Treatment of Major Depression. Clinical Practice Guideline, No. 5. Publication No. 93-0551. Rockville, MD: Department of Health and Human Services, Agency for Health Care Policy and Research; 1993.
3. National Institute for Health and Clinical Excellence (NICE). Depression: The Treatment and Management of Depression in Adults. London, UK: National Collaborating Centre for Mental Health; 2009.
4. Richardson LP, Lewis CW, Casey-Goldstein M, et al. Pediatric primary care providers and adolescent depression: a qualitative study of barriers to treatment and the effect of the black box warning. J Adolesc Health. 2007;40(5):433-439. doi:10.1016/j.jadohealth.2006.12.006
5. Papakostas GI. Initial treatment approaches for patients with major depressive disorder. J Clin Psychiatry. 2009;70(6):e18. doi:10.4088/JCP.8001tx7c
6. Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry. 2009;70(suppl 6):16-25. doi:10.4088/JCP.8133su1c.03
7. Sobczak JA. Managing high-acuity-depressed adults in primary care. J Am Acad Nurse Pract. 2009;21(7):362-370. doi:10.1111/j.1745-7599.2009.00422.x
8. Schulberg HC, Katon W, Simon GE, et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry. 1998;55(12):1121-1127. doi:10.1001/archpsyc.55.12.1121
9. APA Presidential Task Force on Evidence-Based Practice. Evidence-based practice in psychology. Am Psychol. 2006;61(4):271-285. doi:10.1037/0003-066X.61.4.271
10. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Major Depressive Disorder. 2nd ed. Washington, DC: American Psychiatric Association; 2000.
11. Arora NK, McHorney CA. Patient preferences for medical decision making: who really wants to participate? Med Care. 2000;38(3):335-341. doi:10.1097/00005650-200003000-00010
12. Berner MM, Kriston L, Sitta P, et al. Treatment of depressive symptoms and attitudes towards treatment options in a representative German general population sample. Int J Psychiatry Clin Pract. 2008;12(1):5-10. doi:10.1080/13651500701330783
13. Chandra A, Scott MM, Jaycox LH, et al. Racial/ethnic differences in teen and parent perspectives toward depression treatment. J Adolesc Health. 2009;44(6):546-553. doi:10.1016/j.jadohealth.2008.10.137
14. Johnson MD, Meredith LS, Hickey SC, et al. Influence of patient preference and primary care clinician proclivity for watchful waiting on receipt of depression treatment. Gen Hosp Psychiatry. 2006;28(5):379-386. doi:10.1016/j.genhosppsych.2006.07.006
15. Dwight-Johnson M, Sherbourne CD, Liao D, et al. Treatment preferences among depressed primary care patients. J Gen Intern Med. 2000;15(8):527-534. doi:10.1046/j.1525-1497.2000.08035.x
16. Wright A, Jorm AF, Harris MG, et al. What's in a name? is accurate recognition and labelling of mental disorders by young people associated with better help-seeking and treatment preferences? Soc Psychiatry Psychiatr Epidemiol. 2007;42(3):244-250. doi:10.1007/s00127-006-0156-x
17. Cabassa LJ, Zayas LH. Latino immigrants' intentions to seek depression care. Am J Orthopsychiatry. 2007;77(2):231-242. doi:10.1037/0002-9432.77.2.231
18. Givens JL, Houston TK, Van Voorhees BW, et al. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 2007;29(3):182-191. doi:10.1016/j.genhosppsych.2006.11.002
19. Jaycox LH, Asarnow JR, Sherbourne CD, et al. Adolescent primary care patients' preferences for depression treatment. Adm Policy Ment Health. 2006;33(2):198-207. doi:10.1007/s10488-006-0033-7
20. Areán PA, Hegel MT, Reynolds CF III. Treating depression in older medical patients with psychotherapy. Journal of Clinical Geropsychology. 2001;7(2):93-104. doi:10.1023/A:1009581504993
21. Bertocci D, Hirsch E, Sommer W, et al. Student mental health needs: survey results and implications for service. J Am Coll Health. 1992;41(1):3-10. doi:10.1080/07448481.1992.9936300
22. Givens JL, Datto CJ, Ruckdeschel K, et al. Older patients' aversion to antidepressants: a qualitative study. J Gen Intern Med. 2006;21(2):146-151.
23. Hickie IB, Davenport TA, Luscombe GM, et al. The assessment of depression awareness and help-seeking behaviour: experiences with the International Depression Literacy Survey. BMC Psychiatry. 2007;7:48. doi:10.1186/1471-244X-7-48
24. Hickie IB, Luscombe GM, Davenport TA, et al. Perspectives of young people on depression: awareness, experiences, attitudes and treatment preferences. Early Interv Psychiatry. 2007;1(4):333-339. doi:10.1111/j.1751-7893.2007.00042.x
25. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16(12):793-799. doi:10.1046/j.1525-1497.2001.10412.x
26. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782-1787. doi:10.2105/AJPH.94.10.1782
27. Brewin CR, Bradley C. Patient preferences and randomised clinical trials. BMJ. 1989;299(6694):313-315. doi:10.1136/bmj.299.6694.313
28. EndNote. X1 ed. Carlsbad, CA: Thomson ResearchSoft; 2007.
29. Bedi N, Chilvers C, Churchill R, et al. Assessing effectiveness of treatment of depression in primary care: partially randomised preference trial. Br J Psychiatry. 2000;177(4):312-318. doi:10.1192/bjp.177.4.312
30. Chilvers C, Dewey M, Fielding K, et al; Counselling versus Antidepressants in Primary Care Study Group. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ. 2001;322(7289):772-775. doi:10.1136/bmj.322.7289.772
31. Dwight-Johnson M, Unutzer J, Sherbourne C, et al. Can quality improvement programs for depression in primary care address patient preferences for treatment? Med Care. 2001;39(9):934-944. doi:10.1097/00005650-200109000-00004
32. Elkin I, Yamaguchi J, Arnkoff D, et al. "Patient-treatment fit" and early engagement in therapy. Psychother Res. 1999;9(4):437-451. doi:10.1080/10503309912331332851
33. Iacoviello BM, McCarthy KS, Barrett MS, et al. Treatment preferences affect the therapeutic alliance: implications for randomized controlled trials. J Consult Clin Psychol. 2007;75(1):194-198. doi:10.1037/0022-006X.75.1.194
34. Kocsis JH, Leon AC, Markowitz JC, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or their combination. J Clin Psychiatry. 2009;70(3):354-361. doi:10.4088/JCP.08m04371
35. Leykin Y, Derubeis RJ, Gallop R, et al. The relation of patients' treatment preferences to outcome in a randomized clinical trial. Behav Ther. 2007;38(3):209-217. doi:10.1016/j.beth.2006.08.002
36. Lin P, Campbell DG, Chaney EF, et al. The influence of patient preference on depression treatment in primary care. Ann Behav Med. 2005;30(2):164-173. doi:10.1207/s15324796abm3002_9
37. Raue PJ, Schulberg HC, Heo M, et al. Patients' depression treatment preferences and initiation, adherence, and outcome: a randomized primary care study. Psychiatr Serv. 2009;60(3):337-343. doi:10.1176/appi.ps.60.3.337
38. Delini-Stula A, Van Oers H, Van Willigenburg A, et al. Treating depression with different galenical drug formulations: does it make a difference? the comparison of mirtazapine fast dissolving formulation (FDT) with conventional mirtazapine tablets (CT). Int J Psychiatry Clin Pract. 2009;13(2):109-116. doi:10.1080/13651500802485262
39. Granger AL, Fehnel SE, Hogue SL, et al. An assessment of patient preference and adherence to treatment with Wellbutrin SR: a Web-based survey. J Affect Disord. 2006;90(2-3):217-221. doi:10.1016/j.jad.2005.08.018
40. Van HL, Dekker J, Koelen J, et al. Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression. Psychother Res. 2009;19(2):205-212. doi:10.1080/10503300802702097
41. Ward E, King M, Lloyd M, et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression, 1: clinical effectiveness. BMJ. 2000;321(7273):1383-1388. doi:10.1136/bmj.321.7273.1383
42. Dobscha SK, Corson K, Gerrity MS. Depression treatment preferences of VA primary care patients. Psychosomatics. 2007;48(6):482-488. doi:10.1176/appi.psy.48.6.482
43. Gum AM, Areán PA, Hunkeler E, et al. Depression treatment preferences in older primary care patients. Gerontologist. 2006;46(1):14-22.
44. King M, Sibbald B, Ward E, et al. Randomised controlled trial of non-directive counseling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. Health Technol Assess. 2000;4(19):1-83.
45. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
46. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35(6):773-782.
47. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.1136/jnnp.23.1.56
48. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36), 1: conceptual framework and item selection. Med Care. 1992;30(6):473-483. doi:10.1097/00005650-199206000-00002
49. Wisniewski SR, Fava M, Trivedi MH, et al. Acceptability of second-step treatments to depressed outpatients: a STAR*D report. Am J Psychiatry. 2007;164(5):753-760. doi:10.1176/appi.ajp.164.5.753
50. Trivedi MH, Lin EH, Katon WJ. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. CNS Spectr. 2007;12(suppl 13):1-27.
51. Stafford RS, Ausiello JC, Misra B, et al. National patterns of depression treatment in primary care. Prim Care Companion J Clin Psychiatry. 2000;2(6):211-216. doi:10.4088/PCC.v02n0603
52. Stafford RS, MacDonald EA, Finkelstein SN. National patterns of medication treatment for depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry. 2001;3(6):232-235. doi:10.4088/PCC.v03n0611
53. Mendels J, Schless AP. Antidepressant effects of desipramine adminstered in two dosage schedules. Dis Nerv Syst. 1977;38(4):249-251.
54. Morey E, Thacher JA, Craighead WE. Patient preferences for depression treatment programs and willingness to pay for treatment. J Ment Health Policy Econ. 2007;10(2):73-85.
55. Driscoll HC, Karp JF, Dew MA, et al. Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age. Drugs Aging. 2007;24(10):801-814. doi:10.2165/00002512-200724100-00002
56. Saghafi R, Brown C, Butters MA, et al. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatry. 2007;22(11):1141-1146. doi:10.1002/gps.1804
57. Bondolfi G, Aubry JM, Golaz J, et al. A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study. Swiss Med Wkly. 2006;136(5-6):78-85.
58. Schatzberg AF, Rush AJ, Arnow BA, et al. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry. 2005;62(5):513-520. doi:10.1001/archpsyc.62.5.513